Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

HLA class I/II binding tumour associated peptides (ADF-APO-CCN-GUC-K67-MET- MMP-MUC-RGS)

EU orphan designation number: EU/3/07/433
Active ingredient: HLA class I/II binding tumour associated peptides (ADF-APO-CCN-GUC-K67-MET- MMP-MUC-RGS)
Indication: Treatment of renal cell carcinoma
Sponsor: Immatics Biotechnologies GmbH
Paul-Ehrlich-Straße 15, 72076 Tuebingen, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/02/2007 Orphan designation EMEA/OD/059/06 (2007)538 of 15/02/2007
12/08/2016 Removal of orphan designation from Community Register